Summary

Overview
Global Gastric Electrical Stimulators Market reached US$ XX billion in 2022 and is expected to reach US$ XX million by 2030 growing at a CAGR of XX% during the forecast period 2023-2030.
Gastric electrical stimulation, often referred to as implantable gastric stimulation, is the application of particular devices to electrically stimulate the stomach in an attempt to improve gastroparesis or help individuals who are overweight lose weight.
Gastric electric stimulators aim to improve gastric emptying and reduce symptoms such as nausea, vomiting, and abdominal discomfort. Gastric electric stimulators are often considered for individuals with refractory gastroparesis or other motility disorders that do not respond well to conventional treatments.
Market Dynamics
The increasing prevalence of gastroparesis
Gastroparesis is a functional disorder affecting the stomach nerves and muscles. It makes the stomach muscle contractions weaker and slower than they need to be to digest the food and pass it on to the intestines. Gastroparesis is more commonly occur in a diabetic patient. It is estimated that about one-third of cases of gastroparesis are related to diabetes.
For instance, according to the gastrojournal report 2021, the standardized prevalence of gastroparesis was 267.7 per 100,000 persons, whereas the prevalence of “definite” gastroparesis where individuals diagnosed within 3 months of gastric emptying scintigraphy testing with persistent symptoms for more than 3 months was 21.5 per 100,000 persons.
Additionally, the prevalence of idiopathic gastroparesis was 24.8 per 100,000 persons. As with the overall gastroparesis population, prevalence was higher in females than in male individuals and highest in patients aged 58 to 64 years across all subgroups.
Furthermore, significant growth drivers such as the rising patient awareness and demand for gastric stimulators, and technological advancements are expected to drive the market in the forecast period.
High cost of gastric electrical stimulation systems
The costs associated with gastric electrical stimulators, including the device itself, surgery, and follow-up care, can be significant. For instance, the cost of the Enterra Therapy system is US$30,000. The cost of the device and hospitalization in the United Kingdom is £15,000 to £16,000. In Canada the total cost for the device implanted is Can$10,685.
Segment Analysis
The global gastric electrical stimulators market is segmented based on type, application, end user, and region.
The high frequency segment accounted for approximately 42.7% of the market share
The high-frequency segment is expected to hold the largest market share over the period forecast. High-frequency gastric stimulators refer to devices used in the treatment of certain gastrointestinal disorders, particularly gastroparesis. These stimulators are designed to modulate the electrical activity of the stomach to improve gastric motility.
High-frequency gastric stimulators often come with adjustable parameters, allowing healthcare providers to customize the stimulation settings based on individual patient needs. This customization helps optimize treatment outcomes and accommodate variations in patient response.
For instance, in October 2023, the FDA approved Enterra Medical's implantable electrical stimulation device for limited use with magnetic resonance imaging to treat gastroparesis symptoms. Hence, due to the above factors, the segment is expected to hold the largest market share.
Geographical Analysis
North America is expected to hold a significant position in the global gastric electrical stimulators market share
The global gastric electrical stimulators market is segmented into North America, Europe, Asia Pacific, South America, Middle East, and Africa.
North America has maintained a significant market proportion due to factors such as the rising prevalence of gastroparesis and obesity, technological advancements, and increasing healthcare expenditure, this trend is anticipated to continue throughout the forecast period.
For instance, according to the National Institute of Health Report 2022, the prevalence of gastroparesis is 267.7 per 100,000 adults in the United States. Also, approximately 1 in 7 Canadian children and adolescents is obese.
Additionally, according to Forbes Report 2023, 41.9% of adults in the U.S. have obesity. The same data set states that 19.7% of adolescents and children in the United States that is 14.7 million individuals are obese.
COVID-19 Impact Analysis
The COVID-19 pandemic has had a significant impact on the global gastric electrical stimulators market. The onset of the pandemic in early 2020 led to widespread lockdowns and restrictions, impacting regular diagnoses, treatments, drug launches and consultations worldwide. With the outbreak of the pandemic, many pharmaceutical or medical device manufacturing units faced labor shortages and were unable to travel to work due to lockdown restrictions. Therefore, owing to the above factors, the gastric electrical stimulators market is was moderately affected over the forecast period.
Market Segmentation
By Type
• High-frequency
• Low-frequency
By Application
• Gastroparesis
• Obesity
By End User
• Hospitals
• Specialty Clinics
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o U.K.
o France
o Spain
o Italy
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The major global players in the market include Medtronic Plc, ReShape Lifesciences Inc., Changzhou Rishena Medical Device Co. Ltd., Enterra Medical Inc., and InCube Labs among others.
Why Purchase the Report?
• To visualize the global gastric electrical stimulators market segmentation based on type, application, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of gastric electrical stimulators market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.
The global gastric electrical stimulators market report would provide approximately 61 tables, 63 figures, and 185 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

ページTOPに戻る

Table of Contents

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Type
3.2. Snippet by Application
3.3. Snippet by End User
3.4. Snippet by Region
4. Market Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. The increasing prevalence of gastroparesis
4.1.1.2. XX
4.1.2. Restraints
4.1.2.1. High cost of gastric electrical stimulation systems
4.1.2.2. XX
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
7.1.2. Market Attractiveness Index, By Type
7.2. High-frequency*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Low-frequency
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Gastroparesis*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Obesity
9. By End User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Specialty Clinics
9.4. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. UK
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Medtronic Plc
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. ReShape Lifesciences Inc
12.3. Changzhou Rishena Medical Device Co. Ltd
12.4. Enterra Medical Inc.
12.5. InCube Labs
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us